SEARCH BY
| Category | Company |
|---|---|
| Founded | 1849 |
| Sector | Life Science |
| Employees | 81,000 |
| Revenue | 63.6B USD (2024) |
Pfizer is a global pharmaceutical company that is involved in the discovery, development, manufacture, and marketing of a wide range of healthcare products, including medicines and vaccines. The company's portfolio includes treatments across a broad spectrum of areas such as oncology, cardiology, neurology, and infectious diseases, among others. Pfizer was founded in 1849 and is based in New York, New York.
| DEAL STATS | # |
|---|---|
| Overall | 24 of 46 |
| Sector: Life Science M&A | 21 of 41 |
| Type: Add-on Acquisition M&A Deals | 19 of 33 |
| State: Illinois M&A | 1 of 1 |
| Country: United States M&A | 19 of 33 |
| Year: 2015 M&A | 2 of 3 |
| Size (of disclosed) | 5 of 24 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-01-07 |
Redvax
Zurich, Switzerland Redvax is a Swiss, preclinical biopharmaceutical company based in Zurich. Redvax has produced a preclinical human cytomegalovirus (CMV) vaccine candidate, as well as intellectual property and a technology platform related to a second, undisclosed vaccine program. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2015-07-02 |
Pfizer - Ion Channel and Transporter Drug R&D
United States Pfizer - Ion Channel and Transporter Drug R&D platform is a provider of comprehensive services for ion channel and transporter drug discovery, combining Icagen's industry-leading scientific expertise and extensive portfolio of assays and cell lines with XRpro Sciences' proprietary, label-free X-ray fluorescence technology. |
Sell | - |
